Spot on Chimp, the recent PTX200 Anns & all Anns for that matter are written not to hype results, apparently the FDA monitor this closely. From what has been mentioned previously across PTX200 trials, most patients if not all have been heavily pre-treated with not allot of options left. IMO Breast PH2a with 91% ORR restoring chemo resistance & the increasing PFS rate to where we are currently at, is not just encouraging as the Anns suggest, but quite exceptional !!!
PTX Price at posting:
6.3¢ Sentiment: Buy Disclosure: Held
